This article was originally published on The Expose. You can read the original article HERE
Every year, members of the Association of the British Pharmaceutical Industry are required to disclose money that has been paid to healthcare professionals. Disclosures for the year 2022 reveal that AstraZeneca paid doctors for “contracted services” who then appeared on ITV to promote vaccines or downplay vaccine injuries. The affair is being dubbed ITVGate by social media users.
Let’s not lose touch…Your Government and Big Tech are actively trying to censor the information reported by The Exposé to serve their own needs. Subscribe now to make sure you receive the latest uncensored news in your inbox…
Dr. David Cartland tweeted: “#ITVGate has uncovered a massive pyramid of payments from AstraZeneca and Pfizer to doctors in the UK. The same doctors that told you the vaccines were safe and effective and we were all in this together. Oh, and don’t forget to clap, every Thursday, while we rehearse our TikToks. Oh, and that Dave Cartland dude speaking up – we’re going to destroy him so that no doctor will ever speak up again.
“There are 200 pages of recipients of pharma payments – and bear in mind that it is not compulsory to declare these payments in the UK, so this could be the tip of the iceberg.”
Using Disclosure UK Database
The Disclosure UK database aims to ensure transparency in the relationship between the pharmaceutical industry and healthcare professionals (“HCPs”), other relevant decision-makers (“ORDMs”) and healthcare organisations (“HCOs”).
As part of wider efforts to increase transparency, all pharmaceutical companies abiding by The Association of the British Pharmaceutical Industry (“ABPI”) Code of Practice are required to disclose Transfers of Value (“ToVs”) to HCPs, ORDM and HCOs.
The database divides ToV’s into three categories: HCO, HCP and aggregates. ToVs to members of the public are not recorded in Disclosure UK. However, starting with 2022 data, ABPI requires pharmaceutical companies to publish aggregate information about relationships with certain members of the public on their own websites.
Regardless of the recipient, ToVs concerning research and development activities are disclosed as a single, aggregated value in Disclosure UK. For aggregates, no recipient is named.
ToVs related to non-research and development activities are published against individually named recipients, where legally able.[1] ToVs to HCOs are reported under the category of HCO. ToVs to either HCPs or ORDMs are collectively reported under the category of HCPs in Disclosure UK.
There are two ways to peruse Disclosure UK’s database. The first is to search online for a specific name of a healthcare professional, healthcare organisation or pharmaceutical company by clicking on the appropriate icon HERE which will take you to a page where you enter the name in a search field. See the images below for an example.
The second is to download the full dataset and interrogate the data in an Excel workbook. There is a dataset for each of the years 2020, 2021 and 2022. Disclosure UK maintains data on its website for three years, in other words when 2023 data is uploaded, data for 2020 will be removed. There is no dataset which shows an aggregation of the years.
We downloaded the datasets for the three years 2020 to 2022 and aggregated the ToVs for the three years from each pharmaceutical company for the category HCP. We then re-ordered the data to show from the largest to the smallest. So that the file is more compact, we have shown the list in three columns.
In total, pharmaceutical companies have given more than £78 million to healthcare professionals with nearly £63 million coming from just 20 pharmaceutical companies. The top five – AstraZeneca, GlaxoSmithKline plc, Novartis Pharmaceuticals UK Ltd, Pfizer Ltd and Janssen-Cilag Ltd – paid £27.7 million to UK health professionals over the three years.
AstraZeneca Paying Doctors
The top earner from AstraZeneca is Professor David Wheeler who is an expert in the field of kidney medicine. He is an Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust and a Professor of Kidney Medicine at University College London.
Prof. Wheeler has made significant contributions to the development of clinical practice guidelines for several organisations, including Kidney Disease: Improving Global Outcomes (“KDIGO”), of which he is currently co-chair. He has also participated in several large-scale clinical trials testing various treatments for chronic kidney disease.
In 2022, he earned £52,000 from AstraZeneca and an additional £27,000 from other pharmaceutical companies.
The second largest earner from AstraZeneca is Dr. Mona M. Bafadhel, a Professor of Respiratory Medicine at King’s College London and a Consultant Respiratory Physician at Guy’s and St Thomas’ NHS Foundation Trust. She earned £48,000 in 2022 from AstraZeneca for contracted services.
But most interestingly, the 10th top earner from AstraZeneca was Ranjit Singh, a consultant who is represented by Talent4 Media, an agency that manages a variety of TV and radio presenters and experts. AstraZeneca paid Singh £22,500 in 2022 for contracted services.
Singh is a presenter on ITV and he goes by the name of Dr. Ranj Singh or simply Dr. Ranj. For over 10 years, Singh made regular appearances on ITV’s This Morning offering medical advice. He resigned from the show in May 2023 claiming the culture on the show became “toxic” and that he was “managed out” after he tried to raise his concerns.
Here is Singh giving “medical advice” regarding blood clots caused by covid “vaccines.”
AstraZeneca has now admitted in court documents that its covid vaccines cause blood clots and has withdrawn its covid vaccine due to “a decrease in demand.”
And Singh has deleted his Twitter profile.
AstraZeneca recruited other TV doctors as well.
In November 2021, Singh, Dr. Philippa Kaye, Dr. Nighat Arif, Dr. Punam Krishan and Dr. Stephanie Jen Chyi Ooi called for children to get the nasal spray flu vaccine as soon as it is offered through schools or GPs. Their call was part of AstraZeneca’s ‘Share Good Times Not Flu campaign’.
In 2022, Kaye earned £12.500 from AstraZeneca, Arif earned £10,000, Krishan earned £6,000 and Ooi earned £10,000.
There is more to this story, but this article serves as a good starting point. For those who want to find out more, the Twitter handle Jikkyleaks has been tweeting about it in recent days.
Notes:
[1] “Where legally able” refers to regulations surrounding the publication of personal data. Data privacy laws in the UK, General Data Protection Regulation (“GDPR”), mean that to process personal information about a person, companies must choose a lawful basis before they do so. There are six bases to choose from, as defined by the Information Commissioner’s Office (“ICO”), one of them being a person has given clear consent for their personal data to be processed for a specific purpose.
Because of the limitations of obtaining consent, ABPI is now encouraging companies to use “legitimate interests” as their lawful basis for processing people’s data. ABPI is promoting this change in approach to help increase the number of named healthcare professionals and other people in Disclosure UK.
According to the guidance notes for analysis of the Disclosure UK 2022 data:
“The publication of data associated with individuals – whether HCPs or ORDMs – is regulated by the UK Data Protection Act and GDPR requirements in the UK. To date, most companies have used ‘consent’ as the lawful basis to publish information related to individuals. This means that disclosure is dependent on whether individual HCPs and ORDMs provide informed consent for the publication of ToVs that they received from pharmaceutical companies. This poses a challenge in further improving transparency through Disclosure UK as some individuals choose to exercise their rights under the GDPR and do not provide consent. To address this challenge, the ABPI has since encouraged companies to use ‘legitimate interests’ as the lawful basis for processing and disclosing individual data.
“If consent was not obtained from an HCP/ORDM to disclose the ToVs received against their name, or if consent was obtained but subsequently withdrawn, then the ToVs made to that HCP/ORDM were disclosed anonymously in the aggregate figure.
“In the UK, companies are not required to gather consent from HCOs, nor use another legal basis under the Data Protection Act, to disclose their ToVs. In alignment with this, it is not possible to report HCOs in aggregate via Disclosure UK.”
To save our readers having to download the full dataset to read it, we have attached a copy of the ‘Disclosure UK: understanding the data – Guidance notes for analysis of the 2022 data’ dated 16 June 2023 below.
Featured image: It seems someone has something to hide. Source: AmaZeBalls SheZZa on Twitter
This article was originally published by The Expose. We only curate news from sources that align with the core values of our intended conservative audience. If you like the news you read here we encourage you to utilize the original sources for even more great news and opinions you can trust!
Comments